Striant SR (marketed as Striant in the US) is a novel sustained-release mucoadhesive buccal testosterone tablet for the treatment of male hypogonadism. Striant SR restores serum testosterone concentrations to the physiological range within 4 h of application, and steady-state concentrations are achieved within 24 h of twice-daily dosing. In phase III clinical trials, 87-97% of patients using Striant SR achieved 24-h-averaged serum testosterone concentrations within the normal range. In a comp...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
Striant SR: a novel, effective and convenient testosterone therapy for male hypogonadism.
If you are the owner of this record, you can report an update to it here: Report update to this record